Cardiology

ESC statement on trans fatty acids

The American Food and Drug Administration (FDA) considers trans fatty acids (TFA) unsafe for consumption. The FDA is providing a three-year compliance period to allow industry to gradually phase out their use in processed ...

Alzheimer's disease & dementia

Major human drug trial underway for Alzheimer's

A potentially ground-breaking human drug trial is currently underway, which aims to discover whether blood pressure medication can slow or halt the progression of Alzheimer's Disease (AD). This is the latest in EU-funded ...

Cardiology

New biolimus stent equal to everolimus stent at one year

In a match-up of Japan's top drug-releasing stent and a new device featuring a biodegradable coating, the newcomer delivered statistically comparable one-year results, according to data from the NEXT trial presented today ...

Other

Novo Nordisk US shares skid on drug review setback (Update)

Shares of Novo Nordisk tumbled Monday after the Danish drugmaker said U.S. regulators need a new study before they can finish their review of two diabetes treatments, a development that could delay approval for several years.

Cardiology

Radial access should be first choice for PCI, ESC says

The radial approach for percutaneous coronary interventions (PCI) was developed 20 years ago and is used for more than 50% of procedures in France, Scandinavian countries, the UK, Spain and Italy. Despite the advantages of ...

HIV & AIDS

Atherosclerosis found in HIV children

Children with HIV have a 2.5 fold increased risk of atherosclerosis, according to research presented at EUROECHO and other Imaging Modalities 2012. Antiretroviral treatment, lipid lowering drugs and prevention with healthy ...

page 25 from 29